Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov(Russian Academy of Sciences), Stewart T. Cole(Institut Pasteur), Laurent A. Décosterd(University of Lausanne), Anthony Vocat(École Polytechnique Fédérale de Lausanne), Nicolas Widmer(Hôpital de Beaumont), Astrid M. van der Sar(Amsterdam UMC Location VUmc), Florence Pojer(École Polytechnique Fédérale de Lausanne), Paul J. Dyson(École Polytechnique Fédérale de Lausanne), Ruben C. Hartkoorn(Centre National de la Recherche Scientifique), Wilbert Bitter(Vrije Universiteit Amsterdam), Benoît Lechartier(University of Lausanne), Susanne A. Raadsen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Thierry Buclin(Hôpital de Beaumont), Ming Zhang(Johns Hopkins University), O. B. Ryabova(Russian Academy of Sciences), Koen Andries(Janssen (Belgium)), João Neres(École Polytechnique Fédérale de Lausanne)
Cited by 388
Related Papers
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
|Nature|1992|1.3k
Type VII secretion — mycobacteria show the way
|Nature Reviews Microbiology|2007|768
Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
|PLoS Pathogens|2012|567
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
|Nature|1998|566
Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish
|Molecular Immunology|2003|519